VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PACSPACS Group, Inc.
$41.89$6.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPACSBalance Sheet

PACS Group, Inc. (PACS) Balance Sheet

4Y historyFree accessUpdated daily

The company maintains a highly leveraged capital structure with $3.1 billion in total debt and a current ratio of 0.99 as of 2026Q1, indicating limited liquidity buffers.

PACS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Total Current Assets1.07B1.07B938.26M722.15M511.16M
Cash & Short-Term Investments-----
Cash Only-----
Short-Term Investments-----
Accounts Receivable-----
Days Sales Outstanding-----
Inventory-----
Days Inventory Outstanding-----
Other Current Assets86.9M170.63M64.07M48.66M24.92M
Total Non-Current Assets4.6B4.51B4.3B2.79B1.95B
Property, Plant & Equipment4.22B4.17B3.99B2.59B1.78B
Fixed Asset Turnover1.31x1.27x1.03x1.20x1.36x
Goodwill68.06M68.06M60.79M59.02M55.22M
Intangible Assets006.27M6.27M6.27M
Long-Term Investments401.8M87.19M91.38M55.96M48.31M
Other Non-Current Assets-----
Total Assets5.66B5.58B5.24B3.51B2.46B
Asset Turnover0.97x0.95x0.78x0.89x0.98x
Asset Growth %75.38%6.51%49.25%42.68%-
Total Current Liabilities1.07B1B978.43M456.93M483.86M
Accounts Payable180.66M192.23M175.06M140.95M110.58M
Days Payables Outstanding-----
Short-Term Debt162.69M157.53M156.85M16.82M61.36M
Deferred Revenue (Current)0----
Other Current Liabilities730.17M651.67M489.11M0113.5M
Current Ratio0.99x1.07x0.96x1.58x1.06x
Quick Ratio0.99x1.07x0.96x1.58x1.06x
Cash Conversion Cycle-----
Total Non-Current Liabilities3.55B3.63B3.55B2.95B1.91B
Long-Term Debt2.93B3.04B250.98M715.71M438.34M
Capital Lease Obligations0----
Deferred Tax Liabilities0----
Other Non-Current Liabilities-----
Total Liabilities4.62B4.63B4.53B3.41B2.39B
Total Debt3.1B3.2B3.63B2.85B1.93B
Net Debt2.85B3B3.47B2.77B1.86B
Debt / Equity2.97x3.36x5.07x27.97x28.05x
Debt / EBITDA7.00x8.75x22.13x12.19x7.65x
Net Debt / EBITDA6.44x8.21x21.17x11.88x7.39x
Interest Coverage13.74x10.93x3.29x4.15x9.11x
Total Equity1.04B952.45M715.69M101.73M68.65M
Equity Growth %142.95%33.08%603.55%48.18%-
Book Value per Share6.436.084.820.680.46
Total Shareholders' Equity1.04B946.77M709.55M96.13M63.65M
Common Stock157K157K155K1K1K
Retained Earnings390.27M309.58M118.04M96.13M63.65M
Treasury Stock00000
Accumulated OCI00000
Minority Interest5.02M5.68M6.14M5.6M5M

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High financial leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Rapid Expansion Strains Capital Structure

According to recent financial filings, PACS Group has aggressively scaled its total assets from $3.5 billion in 2023Q4 to $5.7 billion by 2026Q1, a trajectory that underscores a rapid acquisition-led growth strategy that has significantly altered the company's underlying balance sheet composition and risk profile.

The rapid asset growth appears to be primarily driven by inorganic expansion, which necessitates constant capital deployment and integration. Investors should monitor whether this pace of growth can be sustained without further diluting equity or increasing reliance on external financing, as the current trajectory suggests a business model heavily dependent on continuous scale.

Leverage Remains Elevated Amid Growth

As reported in quarterly balance sheets, PACS Group maintains a substantial debt load of $3.1 billion as of 2026Q1, with a debt-to-equity ratio that, while improved from the extreme levels seen in 2023, continues to signal a highly leveraged capital structure relative to industry peers.

The persistent reliance on debt to fund facility acquisitions suggests that the company's growth is sensitive to interest rate environments and credit market availability. This leverage profile warrants caution, as the thin operating margins leave little room for error should debt service costs rise or cash flow generation from acquired facilities underperform expectations.

Tight Liquidity Buffers Require Monitoring

Based on the provided financial data, the company's current ratio has fluctuated significantly, settling at 0.99 in 2026Q1, which indicates that current assets are barely sufficient to cover short-term obligations and leaves the firm with a limited buffer against unexpected operational shocks or sudden working capital outflows.

The narrow current ratio suggests that liquidity management is a critical operational constraint for PACS. Investors should consider that such tight liquidity, combined with the capital-intensive nature of skilled nursing operations, may limit the company's flexibility to navigate periods of reimbursement delays or sudden spikes in labor costs.

Equity Base Strengthening Through Retention

As indicated by the company's reported figures, equity has grown from $96.1 million in 2023Q4 to $1.0 billion in 2026Q1, largely driven by the accumulation of retained earnings, which suggests a gradual improvement in the company's internal capital generation capacity over the observed period.

The expansion of the equity base is a positive development that may help offset the company's high debt levels over time. However, the quality of this equity should be scrutinized for potential impacts from stock-based compensation and the sustainability of the earnings that are being retained to support the balance sheet.

PACS — Frequently Asked Questions

Quick answers to the most common questions about buying PACS stock.

What are the total assets of PACS Group, Inc. (PACS)?

As of 2025, PACS Group, Inc. (PACS) had total assets of $5.58B including $1.07B in current assets.

How much debt does PACS Group, Inc. (PACS) have?

PACS Group, Inc. (PACS) carries total debt of $3.20B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of PACS Group, Inc.?

PACS Group, Inc. (PACS) has total shareholders' equity (book value) of $946.8M ($6.08 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is PACS Group, Inc.'s current ratio and liquidity?

PACS Group, Inc. (PACS) reported a current ratio of 1.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.